Niklas Landberg
10PUBLICATIONS
51CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Nov 25, 2025
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes.Henrik Lilljebjörn, Pablo Peña-Martínez, Hanna Thorsson
|Oct 03, 2025
Aberrant expression of SLAMF6 constitutes a targetable immune escape mechanism in acute myeloid leukemia.Carl Sandén, Niklas Landberg, Pablo Peña-Martínez
|Jan 23, 2024
IDH1-Mutant Preleukemic Hematopoietic Stem Cells Can Be Eliminated by Inhibition of Oxidative Phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Dec 13, 2023
IDH1-mutant preleukemic hematopoietic stem cells can be eliminated by inhibition of oxidative phosphorylation.Niklas Landberg, Thomas Köhnke, Yang Feng
|Mar 01, 2023
Reprogramming Cancer into Antigen-Presenting Cells as a Novel Immunotherapy.Miles H Linde, Amy C Fan, Thomas Köhnke
|Nov 16, 2022
The complement receptor C3AR constitutes a novel therapeutic target in NPM1-mutated AML.Sofia von Palffy, Hanna Thorsson, Pablo Peña-Martínez
Pageof 2
Frequent Collaborators
5 joint publications
Vladimir Lj Lazarevic
4 joint publications
Carl Sandén
4 joint publications
Henrik Lilljebjörn
4 joint publications
Ravindra Majeti
4 joint publications
Pablo Peña-Martinez
4 joint publications
Thomas Köhnke
3 joint publications
Sofia von Palffy
3 joint publications
Christina Orsmark-Pietras
3 joint publications
Daniel Thomas
3 joint publications
Yusuke Nakauchi
